Aveanna Healthcare (AVAH) Insider JR Sells $8M of Stock

Insider Robert Williams sold 1 million shares of Aveanna Healthcare Holdings Inc. (NasdaqGS: AVAH) on June 24, 2026. The shares were sold at an average price of $8 each, bringing the total transaction value to $8 million. This sale was not part of a pre-planned trading program.

Insider Buying and Selling at Aveanna Healthcare Holdings Inc.

On June 24, 2026, several insiders sold shares of Aveanna Healthcare. Robert Williams sold 1 million shares at $8 each. On the same day, J.H. Whitney Equity Partners VII, LLC and Paul Vigano each sold shares at the same price, with J.H. Whitney selling 919,389 shares and Vigano selling 1 million shares. Earlier in June, both Williams and Vigano sold 7 million shares each at $6.24 per share.

Other Institutional Activity in Aveanna Healthcare

Several institutional investors made moves with their Aveanna Healthcare holdings. Nut Tree Capital Management, LP increased its position by 550,000 shares, ending with 12,922,649 shares valued at approximately $83.2 million, marking a 4.4% increase. In contrast, BlackRock, Inc. trimmed its holdings by 656,532 shares, now holding 5,500,912 shares worth about $35.4 million, a 10.7% decrease. Summit Partners L P also reduced its stake by 2.1 million shares, bringing its total to 5,451,422 shares valued at $35.1 million, a 27.8% decrease. Meanwhile, Vanguard Capital Management LLC opened a new position with 3,974,819 shares valued at $25.6 million.

Aveanna Healthcare Holdings Inc. Stock Down 36.6%

Shares of Aveanna Healthcare traded at $8.48 on Saturday. The company has a market capitalization of approximately $1.89 billion and a P/E ratio of 7.16. The stock's 52-week range spans from $3.73 to $10.32, with a 50-day moving average of $7.10 and a 200-day moving average of $7.98. Aveanna's beta is 1.93, and it maintains a current ratio of 1.47 and a quick ratio of 1.37, though it has a high debt-to-equity ratio of 623.92.

Recent Earnings

Aveanna Healthcare reported revenue of $2.52 billion, reflecting a growth of 15.9%. The company's earnings per share (EPS) stand at $1.21, with a net margin of 10.37% and a return on equity (ROE) of 3.68%. The next earnings report is expected on August 6, 2026.

Analysts Set New Price Targets

On May 15, 2026, Stephens & Co. upgraded Aveanna Healthcare to a 'buy' rating, setting a price target of $11. On the same day, RBC Capital maintained a 'hold' rating with a $10 target. Earlier, on May 18, Barclays maintained its 'buy' rating with a $9 target. Overall, the consensus recommendation is a 'buy', with a mean target price of $10.05 from 10 analyst opinions.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc., headquartered in Atlanta, Georgia, is a diversified home care platform providing pediatric and adult healthcare services across the United States. The company operates in three segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. Aveanna's services allow patients to receive care at home, reducing the need for more expensive hospital or nursing facility stays. Founded in 2016, the company is led by CEO Jeffrey S. Shaner and employs around 3,500 people.

Bottom Line

Robert Williams' recent sale of Aveanna Healthcare shares highlights ongoing insider activity at the company. Investors keep a close eye on such transactions as they can provide insights into insiders' perspectives on the company's future. It's important to remember that this information reflects past activity and may not indicate current or future positions.